Cite
Tocilizumab in patients with multisystem Erdheim–Chester disease.
MLA
Berti, Alvise, et al. “Tocilizumab in Patients with Multisystem Erdheim–Chester Disease.” OncoImmunology, vol. 6, no. 6, June 2017, p. N.PAG. EBSCOhost, https://doi.org/10.1080/2162402X.2017.1318237.
APA
Berti, A., Cavalli, G., Guglielmi, B., Biavasco, R., Campochiaro, C., Tomelleri, A., Nicoletti, R., Panzacchi, A., Ferrarini, M., & Dagna, L. (2017). Tocilizumab in patients with multisystem Erdheim–Chester disease. OncoImmunology, 6(6), N.PAG. https://doi.org/10.1080/2162402X.2017.1318237
Chicago
Berti, Alvise, Giulio Cavalli, Barbara Guglielmi, Riccardo Biavasco, Corrado Campochiaro, Alessandro Tomelleri, Roberto Nicoletti, Andrea Panzacchi, Marina Ferrarini, and Lorenzo Dagna. 2017. “Tocilizumab in Patients with Multisystem Erdheim–Chester Disease.” OncoImmunology 6 (6): N.PAG. doi:10.1080/2162402X.2017.1318237.